Lebrikizumab, Corticosteroid Regimen May Benefit Eczema Afte

Post-hoc data from the phase 3 ADhere trial shows a lebrikizumab regimen may help patients with atopic dermatitis achieve skin clearance they could not with dupilumab.

Related Keywords

Washington , United States , Lisaa Beck , Eli Lilly , University Of Rochester Medical Center , University Of Rochester Lisaa Beck , Revolutionizing Atopic Dermatitis , Eczema Area Severity Index , Rochester Medical Center , Investigators Global Assessment , Pruritus Numerical Rating Scale ,